Jump to main content
Jump to site search

Issue 4, 2016
Previous Article Next Article

Pharmaceutical cocrystals: along the path to improved medicines

Author affiliations

Abstract

Cocrystals, a long known but understudied class of crystalline solids, have attracted interest from crystal engineers and pharmaceutical scientists in the past decade and are now an integral part of the preformulation stage of drug development. This is largely because cocrystals that contain a drug molecule, pharmaceutical cocrystals, can modify physicochemical properties without the need for covalent modification of the drug molecule. This review presents a brief history of cocrystals before addressing recent advances in design, discovery and development of pharmaceutical cocrystals that have occurred since an earlier review published in 2004. We address four aspects of cocrystals: nomenclature; design using hydrogen-bonded supramolecular synthons; methods of discovery and synthesis; development of pharmaceutical cocrystals as drug products. Cocrystals can be classified into molecular cocrystals (MCCs) that contain only neutral components (coformers) and ionic cocrystals (ICCs), which are comprised of at least one ionic coformer that is a salt. That cocrystals, especially ICCs, offer much greater diversity in terms of composition and properties than single component crystal forms and are amenable to design makes them of continuing interest. Seven recent case studies that illustrate how pharmaceutical cocrystals can improve physicochemical properties and clinical performance of drug substances, including a recently approved drug product based upon an ICC, are presented.

Graphical abstract: Pharmaceutical cocrystals: along the path to improved medicines

Back to tab navigation
Please wait while Download options loads

Publication details

The article was received on 02 Oct 2015, accepted on 02 Nov 2015 and first published on 03 Nov 2015


Article type: Feature Article
DOI: 10.1039/C5CC08216A
Citation: Chem. Commun., 2016,52, 640-655
  •   Request permissions

    Pharmaceutical cocrystals: along the path to improved medicines

    N. K. Duggirala, M. L. Perry, Ö. Almarsson and M. J. Zaworotko, Chem. Commun., 2016, 52, 640
    DOI: 10.1039/C5CC08216A

Search articles by author